Abstract-Association mapping of genetic diseases has attracted extensive research interest during the recent years. However, most of the methodologies introduced so far suffer from spurious inference of the associated sites due to population inhomogeneities. In this paper, we introduce a statistical framework to compensate for this shortcoming by equipping the current methodologies with a state-of-the-art clustering algorithm being widely used in population genetics applications. The proposed framework jointly infers the disease-associated factors and the hidden population structures. In this regard, a Markov Chain-Monte Carlo (MCMC) procedure has been employed to assess the posterior probability distribution of the model parameters. We have implemented our proposed framework on a software package whose performance is extensively evaluated on a number of synthetic datasets, and compared to some of the well-known existing methods such as STRUCTURE. It has been shown that in extreme scenarios, up to 10 À 15 percent of improvement in the inference accuracy is achieved with a moderate increase in computational complexity.
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INTRODUCTION
L ARGE-SCALE projects in life sciences, such as Human Genome Project [1] and HapMap project [2] , [3] , have provided biologists and computer scientists with an invaluable foundation for study and research. In addition, emergence of high throughput sequencing technologies has paved the way to solve the main problems in biology, such as Genome-Wide Association Study (GWAS) [4] . The basic purpose of GWAS is to infer statistical associations between different regions of genome and specific physical or behavioral phenotypes present in living organisms. In many medical applications, as of those considered in this paper, the aforementioned phenotypes are the affection by or vulnerability to a particular genetically-initiated disease. In other words, the goal of GWAS would be to assign specific sites in the DNA sequence, Single Nucleotide Polymorphism (SNP) data or even intensity levels of a microarray experiment to the causal factors underlying a specific disease [5] . During the recent years GWAS methods have been successful in identifying many causal factors for different types of diseases. However, despite major advantages, traditional methods in this area suffer form critical drawbacks.
First, most traditional GWAS frameworks consider genetic variants, such as SNPs, separately and neglect the effect of their biochemical dependencies, a phenomenon called epistasis [6] . This premise may lead to spurious results in occasions where multiple loci are involved in the formation of a complex disease. In other words, multigenetic factors exist in many complex abnormalities since multiple pathways may control a specific biological reaction. In this regard, alternation of each pathway may result into the same disease with highly similar symptoms. This shortcoming usually increases the false discovery rate in limited sample sizes. Recently, a number of researchers have set out to alleviate this problem by introducing various statistical and/or experimental tools [7] , [8] .
The second major shortcoming, which has triggered the idea behind the current paper, is the assumption of genetic homogeneity for the population under study. This assumption is not plausible in real-world datasets since different individuals may have come from different ancestral origins. In such scenarios, also known as "cryptic populations" [9] , attempting a naive association mapping may lead to incorrect outcomes since averaging the statistical results over the whole population produces noisy statistics and decreases the significance levels of the associated genes [10] , [11] , [12] . In addition, self-reported ancestries often do not provide sufficient evidence [13] . In order to rectify this effect several approaches have been proposed, yet each one suffers from its own drawbacks. In particular, majority of previous algorithms use a population stratification strategy to cancel the effect of data structures by clustering the individuals first, and then feeding each cluster to a GWAS module, separately [14] . However, the unsupervised clustering phase ignores the information provided by the disease labels, and its accuracy will highly depend on allele frequencies. This will degrade the performance of the overall framework over small datasets.
In this paper, we address all of the mentioned problems by proposing a novel method for association mapping in the presence of hidden population structures. In other words, it has been assumed that the population under study consists of numerous latent sub-populations with different genetic backgrounds. More importantly, these differences in genetic ancestries are assumed to correlate with distinct genetic vulnerability to the disease, resulting in different disease infection models for each sub-population. We have shown that integration of the distinctions both in allele frequencies and also the disease models highly improves the identification of latent structures as well as associated genetic factors. We have developed a model-based statistical framework which combines genotype clustering algorithms with current association mapping strategies to form a unified mathematical tool with a significantly higher accuracy. The software package for our proposed method can be found at github.com/amirnajafi1990/PopStructGWAS.
The paper is organized as follows. In Section 2 related works in association mapping and GWAS are reviewed. Section 3 explains the basic ideas and mathematical notations in this work. In Section 4, the proposed model is explained, while in Section 5 the statistical inference of model parameters from data is discussed. Section 6 presents our computer simulations and experimental results. Conclusions are made in Section 7.
BACKGROUND AND RELATED WORKS
So far, GWAS methods have been conducted on a wide range of abnormalities and resulted in numerous scientific discoveries. For instance, in [15] , [16] and [17] a number of causal loci for Type I diabetes have been identified, while in [18] , [19] , [20] , [21] the same is carried out for type II diabetes. GWAS methods have also been put to use for more complicated anomalies such as different types of cancer [22] . Researchers in [23] , [24] , [25] , [26] investigate the causal factors for breast cancer, while [27] , [28] , [29] have identified a number of disease-associated genes for prostate cancer. The application of GWAS methods are extended to genetically initiated mental disorders as well, such as Parkinson's disease as in [30] , [31] , [32] , Bipolar Disorder as in [33] , [34] , and Schizophrenia [35] , [36] . Many of such findings are currently being used to diagnose and treat various diseases in gene therapeutic centers worldwide [37] .
Despite novel achievements of GWAS methods [38] , the effect of population structures may generate spurious results. Based on this motivation, a variety of approaches have been proposed by researchers to solve such problems. One approach is to design family-based studies for association mapping instead of case/control groups. Although several versions of these methods exist [39] , most of them are underpowered since the data needed for such methods is difficult to obtain [4] , [40] .
A class of well-known approaches applies appropriate clustering methods to case/control groups in order to identify the latent structures within data. Such methods are used as a preprocessing stage before the actual association mapping. In particular, principal component analysis (PCA) [41] , mixed model approaches [42] and algorithms using the STRUCTURE framework [9] are being widely used. In PCA-based methods, continuous axes of variation with the most amount of information about genetic variability, also known as principal components will be determined, which reveal information regarding population structures of the data [41] , [43] . A faster and more accurate version is proposed in [44] . More recent studies show that PCA is less robust comparing with nonlinear methods such as spectral dimensionality reduction [45] , [46] . Despite of relative improvements in results, top principal components do not necessarily represent true genetic structures since their application lacks an appropriate biological plausibility. The same argument holds for spectral techniques. In fact, they mix structures with long distance LD, family-relatedness or artifacts [47] . In Mixed Model Approaches, the phenotypes are modeled as a mixture of fixed and random effects. These methods, however, may have a lower performance in comparison to their counterparts [47] . Several versions of these methods including [48] , [49] or the faster version in [50] have been proposed so far.
Among the most popular approaches is the seminal work introduced in [9] which is known as a state-of-the-art clustering method based on a Bayesian framework, called STRUCTURE. More recent methods motivated by this approach also exist, see [51] and [52] . As suggested in [9] , one can apply STRUCTURE to case/control groups in an unsupervised scenario to identify hidden structures. As we will show in this paper, this procedure undermines the true potentials of Bayesian estimation in GWAS methodologies. A combination of the many of the above methods is used in [53] where PCA is combined with Random Forest, and also in [54] where PCA meets Linear Mixed Models.
Our proposed algorithm is built upon STRUCTURE. However, it takes the disease infection labels of a GWAS dataset into account during the clustering phase. This way, the disease infection model, i.e., association mapping, and clustering, i.e., identification of latent population structures, will be carried out simultaneously and interactively.
PROBLEM FORMULATION
We are interested in finding the causal genomic variants of a particular phenotype in a given population. In most cases of interest, the observable phenotype is the affection by a particular genetic disease. To this end, N affected and unaffected individuals are sampled from the population. Each individual is labeled indicating whether or not he/she possesses the phenotype.
Each individual is genotyped at L genomic loci. Each locus can take J distinct values indicating distinct allele types obtained either from SNP sets or microsatelite data. As it is mentioned, our primary aim is to infer causal genomic variants of the population given the data D D. In a simplifying model, all affected individuals share the same set of genomic loci as the cause of the given phenotype. In this case, one can perform several statistical inference strategies to obtain the variants given the data. In our more realistic study, however, people in the population are affected differently due to the fact that individuals are originated from K hidden sub-populations and the set of causal variants are different in each sub-population. As discussed before, the presence of such loci in genome is tightly related to genetic evolutionary pathways such as independent genetic drifts. Also, extrinsic evolutionary forces such as natural selection may affect individuals of the same species differently, as a result of the differences in the environmental factors of their habitat.
Our goal is to obtain K different sets of causal variants from the data D D. Note that it is assumed that K is known. In practice, the number of sub-population can be inferred via trial-and-error methods.
Sub-populations are differentiated based on their minor allele frequencies (MAF). In other words, associated with each location ' is a hidden number p j;';k indicating the frequency of the jth allele in the kth sub-population. We use an array P P ¼ ½p j;';k to indicate the MAF of all sub-populations, i.e., P P 2 R JÂLÂK represents the frequency of alleles at each locus for each sub-population.
The ith individual is originated from a sub-population z i 2 f1; . . . ; Kg. We denote the hidden vector of associations to sub-populations by Z Z ¼ ½z i , i.e., Finally, the model underlying the corresponding complex phenotype for the kth sub-population is denoted by M k . In particular, M k indicates the causal genomic loci affecting the kth sub-population. We denote the vector of models by M M, i.e.,
grepresents the disease-causing model in each sub-population.
In fact, M M models the mathematical relation of disease labels with all other parameters of the problem. In Sections 1 and 2, a concise overview of previously introduced models in GWAS, their cons, pros and computational complexities is presented. The most important assumption in this study, is letting the complex disease model M M to vary for each subpopulation. Several recent findings in the pathology of complex genetic diseases support such mathematical assumption [5] , [11] , [17] . This is due to the fact that functional misbehavior of vital processes in living organisms can occur from multiple sources of genetic abnormalities rather than one. 
THE PROPOSED MODEL
We need to present a model incorporating our knowledge into the priors, i.e., defining PðH HÞ, and the way data are generated from the hidden parameters, i.e., defining the conditional distribution PðD DjH HÞ.
Modeling of Prior Distributions
We assume statistical independence among prior knowledge of allele frequencies P P , information regarding subpopulations of origin Z Z and also the disease causing models M M, as in [9] . This assumption is biologically plausible since in reality there are not much evidence for statistical linkage of these quantities, i.e., PðH HÞ ¼ PðP P ÞPðZ ZÞPðM MÞ:
To model PðP P Þ, we note that p Ã;';k ¼ p 1;';k ; p 2;';k ; . . . ; È p J;';k g is a probability distribution and it sums to one. Therefore, similar to [9] , we use the Dirichlet distribution to model the allele frequencies
where s are user-specific parameters, all of which can be set to one in case there is no prior information. We also assume that p Ã;';k for ' and k are independent. Assuming no prior information regarding memberships of individuals, a random individual belongs to each of the K sub-populations with equal probabilities, i.e., 1=K. By independent sampling of individuals, hence, we obtain
In order to discuss the mathematical models of a complex disease, we first take into account a number of biologically related assumptions. First, it is assumed that all the individuals are labeled in correspondence with one particular genetic disease. Moreover, we assume that the disease of interest has multigene causal pathways. In other words, the biological complexity of the disease strongly suggests that different, and apparently independent genetic abnormalities may lead to the same misfunctionality in body. In this regard, it would be reasonable to assume that different subgroups of a population are associated with different causal factors which justifies decomposing the disease model into K independent sub-models, where each sub-model is related to a specific genetic sub-population.
Based on the above-mentioned assumptions, a general mathematical model for a complex genetic disease in each sub-population assumes statistical dependence between the disease and a particular group of SNPs or genetic variations. Mathematically speaking, disease-associated sites denoted by S can be decomposed into S 1 ; S 2 ; . . . ; S K f g , where S k includes all the loci associated with the disease in the kth sub-population. It should be noted that loci sets S k are free to have non-zero overlaps, also, some S k s can even be equal. In fact, we let different sub-populations to have different disease-causing factors, but do not force them to.
Various assumptions regarding S k j j, i.e., the number of causal loci in the kth sub-population, can be made. A naive approach would be to consider single locus hypothesis testing which ignores epistatic relations among genetic sites. More complicated assumptions incorporate investigation of multiple genetic markers instead of one which leads to better results, yet suffer from highly increased computational burdens. We have assumed S k j j to be drawn from a Poisson distribution with an adjustable parameter h k
User can choose large values for h k in order to incorporate more associated variants in the model. This, in turn, increases the computational complexity of the resultant inference schemes.
An appropriate prior for choosing elements in each S k is to promote those combinations of loci which are physically close to each other in genome. This way, local epistatic relations in formation of a complex disease can be appropriately addressed. One can write the conditional probability distribution P S k j S k j j ð Þas
where PðS
k Þ is a uniform distribution over those loci that are located in a D neighborhood of at least one of the previously determined causal loci, i.e., S
where
Again, D is a user specific parameter and indicates the extent of epistasis in genome which we wish to consider.
Choosing small values for D, significantly reduces the computational complexity in the inference stage, however, forces the disease-associated loci to be close to each other. Obviously, letting D to be equal to genome length, results in conventional methodologies of loci testing. Based on the above assumptions, the prior distribution for the disease model can be expressed as
Data Modeling
To model the generation of data given the hidden parameters, we note that
Therefore, we discuss about the two factors separately. First, we argue that
This is due the fact that, in our model, individuals attain their genomic variants from the sub-population that they are originated from, and the disease model only affects people with certain genotypes. For the sake of simplicity, we assume linkage equilibrium among genetic loci as well as Hardy-Weinberg equilibrium in each sub-population of origin. In addition, the sub-population specific frequencies between different groups are completely independent. In proceeding sections, these assumptions enable us to draw independent samples from the allele frequency distributions. Considering statistical independence among different loci, genotype matrix probability distribution can be formulated by a series of multinomial functions as follows:
where x a ð Þ n;' denotes the genotype of the nth individual in his/her 'th locus of the ath chromosome (here we have focused on diploid organisms such as humans).
To model the second factor in Equation (9), we note that
This is due to the fact that whether or not a person is affected is independent of the MAFs of his/her sub-population. Considering independence in susceptibilities of individuals to the given disease, one can write
P y n jX X n ; z n ; M n ð Þ :
Given z n and M n , one can obtain the causal loci of the disease for each person of interest. Let us denote this set of loci for the nth individual by W n . Obviously, W n can take J 2jS zn j possible combinations. Each combination for W n infects the individual with an unknown probability denoted by F z n W n ð Þ. Hence,
A Bayesian network can be used to capture all the dependencies between data and hidden parameters. Fig. 1 presents the graphical model of this network.
INFERENCE
In the Bayesian inference framework, we would like to obtain the posterior of the hidden parameters given the data, i.e., PðH HjD DÞ. In this section, we present an algorithm based on the Markov-Chain Monte-Carlo (MCMC) method to achieve such a goal.
It is worth mentioning that the proposed statistical model presented in the preceding section can be viewed as a generalisation of the model used by STRUCTURE for unlabelled datasets. In particular, if we remove the labels from our model, the Bayesian inference amounts to unsupervised clustering of individuals based on their genotyped data which has been previously carried out in [9] . In a GWAS, however, we wish to incorporate labeled data samples and take advantage of the additional information provided by labels during the inference.
Conventional frameworks intend to correct for the effect of population stratification by first clustering the data samples, and then feeding each cluster of data into a GWAS module to infer causal factors in a separate phase. We show that clustering and finding causal disease factors are needed to be inferred simultaneously.
MAP Estimation via Gibbs Sampling
We set out to elaborate upon previously developed numerical methods to maximize P H HjD D ð Þ, which indicates the posterior probability distribution of allele frequencies, subpopulation memberships and the disease models based on an observed dataset. In order to do so, we have taken advantage of the Markov-Chain Monte-Carlo (MCMC) methods, and in particular Gibbs Sampling, which has demonstrated top-notch performances in a variety of applications, and also is easy to implement.
There are a handful of problems in which independent samples from a known distribution pðu 1 ; u 2 ; u 3 ; . . . ; u n Þ are needed. However, direct sampling from p is not numerically tractable. Gibbs sampling guarantees tractable generation of independent samples which converge to the desired distribution p, should the ergodicity condition is satisfied. The procedure for generating these samples is as follows:
. . .
It is shown that for sufficiently large number of iterations, the above Markov chain closely imitates the desired distribution. The number of iterations between two consecutive samples, shown by c, should also be sufficiently large. Fortunately, it is easy to show that these conditions hold for the problem at hand, thus making the MCMC method applicable to our algorithm.
The analogy between the model at hand and the Gibbs sampling framework mentioned above becomes clear by replacing u 1 ; u 2 ; u 3 ð Þ with P P ; M M; Z Z ð Þ . However, our experimental observations confirm that maximizing the posterior distribution for disease models in the final stage of each iteration, instead of sampling from it, results in higher convergence rates. Hence, the sampling of the posterior probabilities can be done by iterating the following steps:
, where m denotes the index of previous iteration.
Inference of Allele Frequencies
Since minor allele frequencies P P are independent of the disease model, the first step of the proposed inference algorithm can be simplified into sampling of P P m ð Þ from P P P jX X; Z Z mÀ1 ð Þ À Á . Recall from Section 4 that the prior distribution for allele frequencies, i.e., P P P jZ Z mÀ1 ð Þ À Á , is modeled via a Dirichlet distribution with parameters 1 ; . . . ; J . Also, P X XjP P ; Z Z mÀ1 ð Þ À Á which resembles the probabilistic model for generating genotype data from MAFs is assumed to be a multinomial probability distribution. Hence, the posterior probability distribution for allele frequencies can be written as
where D indicates a Dirichlet distribution with parameters j þ n j;';k ; j ¼ 1; 2; . . . ; J. The relation in (15) directly follows from the fact that Dirichlet distribution is the conjugate prior for multinomial distribution. s are user-specific parameters while the quantities n j;';k are defined as
In other words, n j;';k represents the number of chromosomes in the kth sub-population of the dataset which contain the jth allele type in their 'th genetic locus. These parameters indicate the empirical abundance of specific allele types in each locus and sub-population.
Inference of Sub-Population Memberships
In the second step of the algorithm, each person is assigned to a cluster based on current estimates of other target variables and also observed data. Mathematically speaking, one has to sample from the posterior distribution P Z ZjX X; 
For the nth individual the equation reduces to the following form P z n ¼ kjy n ; X X n ; M M ðmÀ1Þ ; P P
Once (18) is computed for all k 2 1; 2; . . . ; K f g , we can normalize the quantities in order to attain a discrete probability distribution. z m ð Þ n can then be achieved by sampling from this discrete probability distribution.
Inference of Disease Models
The final step of our modified Gibbs sampling procedure corresponds to finding the most probable disease models for each sub-population according to the posterior probability distribution of M k s, i.e., P M MjX X; Y Y ; Z Z m ð Þ À Á . It should be reminded that given the genotype data of an individual, his/her infection to the disease is assumed to be independent from MAFs. A notable fact is that M M k may be inferred solely from X X n ; y n ; z n ð Þ j n ¼ 1; 2; . . . ; N f g . In this regard, the inference can be done by any of the previously introduced disease model identification methods in the GWAS literature. However, in this study we use our general disease model proposed in Section 4.2.
It is clear that the formulation P M MjX X; Y Y ; Z Z m ð Þ À Á can be written as
By replacing the equations from (14) into (19), one can alternatively have
Disease model selection step implies the maximization of P M MjX X; Y Y ; Z Z ðmÞ À Á with respect to variables S k and F k : ð Þ for all k ¼ 1; 2; . . . ; K. It is easy to investigate that maximization with respect to probabilities F k :
ð Þ has an analytical solution. Optimal disease probabilities at the mth iteration, F m ð ÞÃ k , can be obtained via the following ratio, denoted by disease enrichment ratio (calculations are presented in the Appendix A)
where C k;i 2 1; 2; . . . ; J f g 2jS k j represents the ith combination of the causal factors in the kth sub-population. V k;i and v k;i are defined as
In other words, V k;i represents the number of individuals in the kth sub-population, which have the particular combination of minor-major alleles C k;i in their disease-associated loci S k . v k;i is the number of those loci that have
. . . ; K are calculated independently for each cluster as well as for the observed combinations C k;i . It should be noted that only the observed allele combinations does matter, so the computational complexity of forming disease enrichment ratios and further computations are O N ð Þ.
The intuition behind Equation (22) seems obvious, since the probability of disease infection for a group of individuals with a particular allele combination and in a specific subpopulation is estimated by the empirical ratio of those who are infected, to the number of all the individuals having that combination. By substituting the optimal disease infection probabilities into (14) , the following formulation is achieved
where n k;i denotes the number of chromosomes with
Þ denotes the Shannon entropy. Likewise, P k;i indicates the empirical ratio of disease infection in the kth subpopulation for those individuals with the allele combination C i;k . Again, the proof is given in Appendix A.
Maximization of (20) with respect to the remaining variables, i.e., the sets S k ; k ¼ 1; 2; . . . ; K, does not have an analytical solution and should be determined via exhaustive searching in a valid solution space. This is an essential step in almost all GWAS methodologies. Mathematically speaking, for all possible choices of S k j j and loci in S k the following objective function should be evaluated and consequently maximized
The above optimization problem, in its simplest form, requires a search on the total possible subsets of SNPs to be solved which renders this approach inapplicable even for moderate numbers of SNP loci. However, it should be noted that by choosing h (the expected number of genetic loci involved in the formation of disease) wisely, one can control the computational complexity of the search. In other words, genetic diseases are mostly caused by abnormalities in a limited number of SNPs, say < 10, rather then the whole set of SNPs in genome $ 10 6 . This fact will significantly reduce the search space since for S k j j ) h the objective function in (24) becomes negligible and should not be checked. Moreover, by imposing the prior assumption regarding the consideration of epistasis only for neighboring SNPs (choosing relatively small values for epistasis length D) the valid search space will be reduced even further and the computational complexity of the optimization becomes practically tractable, i.e., migrating from an exponentially large number o possible combinations into a polynomial function of genome length.
Under mild condition including the ergodicity criteria, one can investigate that the series . . .
for sufficiently large m and c will resemble independent samples of the posterior distribution of the overall model. It should be noted that initial value of P P , M M and Z Z, denoted by P P 
EXPERIMENTAL RESULTS
In this section, the experimental results of the proposed statistical framework are presented. Moreover, performance of our method has been compared with conventional GWAS methodologies as well as state-of-the-art clustering frameworks in the area of population genetics. We will show that the proposed framework surpasses both conventional GWAS algorithms and unsupervised clustering methods in determining the associated factors to the disease and also identifying the hidden population structures. The next part will discuss experimental results over synthetic data in addition to providing explanations regarding the generation of these datsets. Final part of the section is devoted to representation and analysis of computer simulations and comparisons.
Synthetic Data
In order to test the performance of our algorithm, we developed simulated data using our data generation model discussed in Section 4 whose hidden parameters were known prior to testing our framework. The data generation model takes into account realistic assumptions underlying living organisms such as population stratification, genetic barriers and linkage equilibrium.
For the sake of simplicity, we have assumed that the dataset consists of two hidden sub-populations, i.e., K ¼ 2. Inspired by the attributes of real genotyped datasets, we have also assumed that most of the genotyped loci have same MAFs in both sub-populations, which are considered as random values in the range 0; 0:1 ð Þ. Consequently, only a small fraction, denoted by g, of the loci have sub-population specific frequencies and thus can be useful during the clustering; However, these loci are not assumed to be known a priori. We have assumed g ¼ 5 percent in all of our simulations while the number of geotyped loci varies between 20 and 5000.
In the next phase, disease labels will be generated for each individual based on the statistical infection model discussed in the preceding sections. Number of disease-associated factors and corresponding genetic loci are determined through random sampling from prior distributions with h ¼ 2 (expected number of associated loci) and D ¼ 10 (the physical extent of linkage disequilibrium in genome). It is worth mentioning the associated loci are assumed to be different in each sub-population. This assumption models the fact that several different malfunctions in the biological pathways lead to the same disease. Moreover, a number of possible allele combinations of associated factors are chosen to be disease causing, i.e., with F C i;k À Á > 0:7 which implies a high risk of infection if C i;k is exposed, while the other combinations are assumed to be neutral, i.e., F C i;k À Á < 0:05. According to therapeutic properties of many complex diseases, combination of minor alleles at SNP loci with a moderate or higher linkage disequilibrium have been identified as the main associated factor of the illness [4] , [5] . These assumptions are appropriately addressed during the data generation phase via parameter settings. Finally, it should be noted that the total number of iterations and the burn-in period for our MCMC implementation are set to 20000 and 10000, respectively.
Results
We have compared the performance of our method to STRUCTURE [9] , in determining the hidden sub-populations within the dataset. STRUCTURE is known as the state-of-theart unsupervised clustering algorithm for genotype data. The results are depicted in Figs. 2 and 3 for datasets of size Fig. 2 . Accuracy in identification of hidden sub-populations as a function of the number of genetic loci, for our proposed method and the STRUC-TURE framework with both all data points and cases only. Dataset consists of overall 600 individuals, and only 5 percent of genetic loci have different allele frequencies between the two hidden sub-populations. The proposed method surpassed the state-of-the-art, specifically in low loci number regimes. Fig. 3 . Accuracy in identification of hidden sub-populations as a function of the number of genetic loci, for our proposed method and the STRUC-TURE framework with both all data points and cases only. Dataset consists of overall 1,000 individuals, and only 5 percent of genetic loci have different allele frequencies between the two hidden sub-populations. As can be seen the performance of STRUCTURE in "cases only" mode has been improved, however, the proposed method still performs better.
N ¼ 600 and 1000, respectively. STRUCTURE ignores the disease labels since its core algorithm is designated for unsupervised scenarios. However, we have observed that if use only the case group, i.e., the group with y n ¼ 1, the performance of STRUCTURE will improve for large datasets. However, it is evident that for small number of loci, i.e., L < 1000, the proposed framework has a significantly improved performance over STRUCTURE and its variant. Moreover, in extreme scenarios STRUCTURE has an accuracy around 50 percent in a two-class problem which renders this method inapplicable in such cases. The mentioned supermacy for the proposed method is due to employment of disease labels and an appropriate disease model during the inference, while STRUC-TURE only uses only allele types in informative loci. Fig. 4 illustrates the region in N-L plane (number of individuals versus number of genotyped loci) in which the methods have shown a clustering accuracy of 80 percent or higher. In this regard, the borders of this region is shown for the proposed method and STRUCTURE in blue and red colors, respectively. As it can be seen, the proposed method encompasses a relatively larger area in the plane which indicates the method outperforms unsupervised clustering algorithms when the number of individuals or the number of genotyped loci are small. It worth mentioning that for practical reasons it is common for researchers to reduce the number of genotyped loci in genome-wide association study since the inherent complexity of the problem usually scales exponential with L. On the other hand, the number of individuals in a GWAS dataset is limited due to financial issues in acquiring of the data samples.
An important aspect of any GWAS methodology is its capability for correct identification of disease-associated sites in a given dataset. The performance of the proposed framework is shown in Fig. 5 where a number of Manhattan plots are depicted to show the statistical significance level of the genetic loci being tested. By statistical significance we simply mean Àlog p-value ð Þ , where all p-values are computed according to the hypothesis of being a associated factor. As it can be seen, the significance level of the main associated loci corresponding to each of the hidden subpopulations are relatively small, hence, resulting into spurious inferences (blue plots). The main reason for this phenomenon is the lack of an appropriate population stratification to separate different case/control groups. As a result, different sub-populations would suppress the significance level of each other by introducing noisy signals. However, effective clustering of the dataset and computing the significance level of each associated factor only within its corresponding sub-population achieves a considerably higher significance level and avoids mis-identifications. the latter can be achieved by our proposed framework while conventional clustering algorithms have been failed to effectively find the latent population structures. In order to further illustrate the performance of the proposed method we have compared its accuracy with five rival methodologies. The rival methods are simple singlelocus and bi-locus hypothesis testing algorithms implemented in PLINK toolbox [55] , an improved genetic algorithm (IGA) framework introduced in [56] , GBOOST which is designated to capture mutual epistatic relations [57] , simple hypothesis testing with a PCA-based population stratification module [41] , and a GWAS method inspired by linear support vector machines (SVM) proposed in [7] . Two sets of datasets have been used for this experiment, which consist of K ¼ 1 and K ¼ 2 hidden sub-populations, respectively. The proposed method is compared with the STRUCTURE framework. It can be seen that our method has an acceptable performance in a relatively larger area of the plane, implying a more robust performance for small size datasets. The achieved improvement is due to employing disease infection labels during the clustering. The results have been shown in Table. 1. It should be noted that parameters for each method have been tuned to achieve the best performance. For the case of K ¼ 1 almost all methods have an acceptable performance, while PLINK and GBOOST perform marginally better. However, it can be observed that when there are strong hidden population structures, as in the case of K ¼ 2, the accuracy of the proposed framework has significantly surpassed the rivals. As a result, all the mentioned methodologies face with spurious statistical inferences which result in erroneous decisions. Also, it has been seen that PCA-based methods for population stratification are not useful in extreme cases.
In order to observe the performance change of the proposed algorithm with respect to increase in the number of sub-populations K, we have tested the accuracy of clustering for values of K 2 2; . . . ; 18 f g whose results are shown in Fig. 6 . In this experiment, the number of individuals have been kept between 100 to 150 for each sub-population in order to maintain a fair comparison. As can be seen, the accuracy of our association mapping scheme is considerably high even for relatively large number of sub-populations, i.e., K $ 10. For 3 < K < 6, the gap between clustering accuracy of the proposed method and STRUCTURE is significant, which should be the result of adding disease label information. However, when the number of hidden sub-groups is more than this limit, the performance of our algorithm and that of STRUCTURE becomes similar, which is still significantly higher than PCA-based or random clustering.
Our proposed scheme is based on MCMC and thus does not follow a deterministic approach to find the hidden structures and disease-associated variants. In this regard, we have set out to experimentally analyze the stability of our method in different runs on random subsets of a particular dataset. We have measured the average variance of clustering output over all individuals, in independent runs of our algorithm and also STRUCTURE. Also, we have repeated this experiment for 5 different population sizes, i.e., N ¼ 50; 100; 150; 200; 250. Results are shown in Table. 2. As can be seen, the variance of our proposed algorithm is quite low, which yields a desirable stability in clustering and association mapping.
CONCLUSIONS
Population structures are shown to have a tremendous impact on the accuracy of many genome-wide association mapping studies. The majority of methods which are intended to rectify this shortcoming are based on unsupervised clustering of genotype data in a preprocessing stage to cancel the effect of population structures, and then feeding each cluster for a GWA study separately. This strategy confronts sever problems in small-size datasets since the MAFs do not necessarily suffice for robust identification of sub-populations. On the other hand, a variety of recent medical discoveries verify that most of complex diseases are multigene and thus may have several infection models according to genome. Based on this fact, this paper proposes a novel statistical framework to perform association mapping and population structure identification simultaneously and interactively. We have shown that in extreme scenarios, such as many real-world datasets, the accuracy of the proposed framework in identifying population structures can be improved up to 10 to 15 percent. Moreover, false discovery rate in association mapping stages are dropped dramatically.
In our future works, we will mainly focus on the effect of population admixtures, i.e., multiple genetic ancestries for each individual, which has been neglected in this study for simplicity. In addition, it is possible to transform the mathematical core of the current study from a parametric 
Two sets of datasets have been employed for this test which consists of K ¼ 1 and K ¼ 2 hidden sub-populations, respectively. As can be seen, when K > 1 the proposed method outperforms rival algorithms. For a considerable range of K, the performance gap between our algorithm and STRUCTURE is significant. Each standard deviation is computed over 10 independent runs on random subsets of a same dataset. As can be easily seen, both algorithms are clearly stable and produce almost deterministic outputs.
viewpoint, to a Bayesian non-parametric setting which is shown to be more robust against parameter configurations.
APPENDIX A ANALYTIC SOLUTION FOR DISEASE INFECTION PROBABILITIES
In this section we provide the proof for obtaining Equations (22) and (23) . 
Obviously, only the two last summands depend on infection disease probabilities. Since W n is not continuous and takes only discrete values, one can rewrite the mentioned summands as:
where C i;k indicates the ith possible combinations of 2 S k j j alleles. The factor of 2 corresponds to the diploid assumption. Accordingly, R i;k ¼ njW n ¼ C i;k ; z m ð Þ n ¼ k È É . By calculating the derivatives of (26) with respect to F k C i;k À Á and omitting the constant factors, the above equation is simplified to
which alternatively means
P i;k indicates the empirical disease infection ratio for individuals in R i;k . By substitution of the above optimal disease infection probabilities into (26) , one simply achieves the following equation in terms of S k and the inputs of the original problem
where H Á ð Þ denotes the Shannon entropy. As a result, we have
which is Equation (23) and the proof is complete.
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